Global Liposomal Irinotecan Market Growth 2022-2028
- LP 4759403
- 72 Pages
- January 2022
- Pharmaceuticals
The United States Liposomal Irinotecan market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Liposomal Irinotecan market, reaching US$ million by the year 2028. As for the Europe Liposomal Irinotecan landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Liposomal Irinotecan players cover Ipsen, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomal Irinotecan market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
43mg
50mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Ipsen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposomal Irinotecan Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Liposomal Irinotecan by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Liposomal Irinotecan by Country/Region, 2017, 2022 & 2028
2.2 Liposomal Irinotecan Segment by Type
2.2.1 43mg
2.2.2 50mg
2.3 Liposomal Irinotecan Sales by Type
2.3.1 Global Liposomal Irinotecan Sales Market Share by Type (2017-2022)
2.3.2 Global Liposomal Irinotecan Revenue and Market Share by Type (2017-2022)
2.3.3 Global Liposomal Irinotecan Sale Price by Type (2017-2022)
2.4 Liposomal Irinotecan Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Liposomal Irinotecan Sales by Application
2.5.1 Global Liposomal Irinotecan Sale Market Share by Application (2017-2022)
2.5.2 Global Liposomal Irinotecan Revenue and Market Share by Application (2017-2022)
2.5.3 Global Liposomal Irinotecan Sale Price by Application (2017-2022)
3 Global Liposomal Irinotecan by Company
3.1 Global Liposomal Irinotecan Breakdown Data by Company
3.1.1 Global Liposomal Irinotecan Annual Sales by Company (2020-2022)
3.1.2 Global Liposomal Irinotecan Sales Market Share by Company (2020-2022)
3.2 Global Liposomal Irinotecan Annual Revenue by Company (2020-2022)
3.2.1 Global Liposomal Irinotecan Revenue by Company (2020-2022)
3.2.2 Global Liposomal Irinotecan Revenue Market Share by Company (2020-2022)
3.3 Global Liposomal Irinotecan Sale Price by Company
3.4 Key Manufacturers Liposomal Irinotecan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposomal Irinotecan Product Location Distribution
3.4.2 Players Liposomal Irinotecan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Liposomal Irinotecan by Geographic Region
4.1 World Historic Liposomal Irinotecan Market Size by Geographic Region (2017-2022)
4.1.1 Global Liposomal Irinotecan Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Liposomal Irinotecan Annual Revenue by Geographic Region
4.2 World Historic Liposomal Irinotecan Market Size by Country/Region (2017-2022)
4.2.1 Global Liposomal Irinotecan Annual Sales by Country/Region (2017-2022)
4.2.2 Global Liposomal Irinotecan Annual Revenue by Country/Region
4.3 Americas Liposomal Irinotecan Sales Growth
4.4 APAC Liposomal Irinotecan Sales Growth
4.5 Europe Liposomal Irinotecan Sales Growth
4.6 Middle East & Africa Liposomal Irinotecan Sales Growth
5 Americas
5.1 Americas Liposomal Irinotecan Sales by Country
5.1.1 Americas Liposomal Irinotecan Sales by Country (2017-2022)
5.1.2 Americas Liposomal Irinotecan Revenue by Country (2017-2022)
5.2 Americas Liposomal Irinotecan Sales by Type
5.3 Americas Liposomal Irinotecan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomal Irinotecan Sales by Region
6.1.1 APAC Liposomal Irinotecan Sales by Region (2017-2022)
6.1.2 APAC Liposomal Irinotecan Revenue by Region (2017-2022)
6.2 APAC Liposomal Irinotecan Sales by Type
6.3 APAC Liposomal Irinotecan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Liposomal Irinotecan by Country
7.1.1 Europe Liposomal Irinotecan Sales by Country (2017-2022)
7.1.2 Europe Liposomal Irinotecan Revenue by Country (2017-2022)
7.2 Europe Liposomal Irinotecan Sales by Type
7.3 Europe Liposomal Irinotecan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposomal Irinotecan by Country
8.1.1 Middle East & Africa Liposomal Irinotecan Sales by Country (2017-2022)
8.1.2 Middle East & Africa Liposomal Irinotecan Revenue by Country (2017-2022)
8.2 Middle East & Africa Liposomal Irinotecan Sales by Type
8.3 Middle East & Africa Liposomal Irinotecan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomal Irinotecan
10.3 Manufacturing Process Analysis of Liposomal Irinotecan
10.4 Industry Chain Structure of Liposomal Irinotecan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposomal Irinotecan Distributors
11.3 Liposomal Irinotecan Customer
12 World Forecast Review for Liposomal Irinotecan by Geographic Region
12.1 Global Liposomal Irinotecan Market Size Forecast by Region
12.1.1 Global Liposomal Irinotecan Forecast by Region (2023-2028)
12.1.2 Global Liposomal Irinotecan Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liposomal Irinotecan Forecast by Type
12.7 Global Liposomal Irinotecan Forecast by Application
13 Key Players Analysis
13.1 Ipsen
13.1.1 Ipsen Company Information
13.1.2 Ipsen Liposomal Irinotecan Product Offered
13.1.3 Ipsen Liposomal Irinotecan Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ipsen Main Business Overview
13.1.5 Ipsen Latest Developments
14 Research Findings and Conclusion
Table 1. Liposomal Irinotecan Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Liposomal Irinotecan Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 43mg
Table 4. Major Players of 50mg
Table 5. Global Liposomal Irinotecan Sales by Type (2017-2022) & (K Units)
Table 6. Global Liposomal Irinotecan Sales Market Share by Type (2017-2022)
Table 7. Global Liposomal Irinotecan Revenue by Type (2017-2022) & ($ million)
Table 8. Global Liposomal Irinotecan Revenue Market Share by Type (2017-2022)
Table 9. Global Liposomal Irinotecan Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Liposomal Irinotecan Sales by Application (2017-2022) & (K Units)
Table 11. Global Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Table 12. Global Liposomal Irinotecan Revenue by Application (2017-2022)
Table 13. Global Liposomal Irinotecan Revenue Market Share by Application (2017-2022)
Table 14. Global Liposomal Irinotecan Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Liposomal Irinotecan Sales by Company (2020-2022) & (K Units)
Table 16. Global Liposomal Irinotecan Sales Market Share by Company (2020-2022)
Table 17. Global Liposomal Irinotecan Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Liposomal Irinotecan Revenue Market Share by Company (2020-2022)
Table 19. Global Liposomal Irinotecan Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Liposomal Irinotecan Producing Area Distribution and Sales Area
Table 21. Players Liposomal Irinotecan Products Offered
Table 22. Liposomal Irinotecan Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Liposomal Irinotecan Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Liposomal Irinotecan Sales Market Share Geographic Region (2017-2022)
Table 27. Global Liposomal Irinotecan Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Liposomal Irinotecan Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Liposomal Irinotecan Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Liposomal Irinotecan Sales Market Share by Country/Region (2017-2022)
Table 31. Global Liposomal Irinotecan Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Liposomal Irinotecan Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Liposomal Irinotecan Sales by Country (2017-2022) & (K Units)
Table 34. Americas Liposomal Irinotecan Sales Market Share by Country (2017-2022)
Table 35. Americas Liposomal Irinotecan Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Liposomal Irinotecan Revenue Market Share by Country (2017-2022)
Table 37. Americas Liposomal Irinotecan Sales by Type (2017-2022) & (K Units)
Table 38. Americas Liposomal Irinotecan Sales Market Share by Type (2017-2022)
Table 39. Americas Liposomal Irinotecan Sales by Application (2017-2022) & (K Units)
Table 40. Americas Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Table 41. APAC Liposomal Irinotecan Sales by Region (2017-2022) & (K Units)
Table 42. APAC Liposomal Irinotecan Sales Market Share by Region (2017-2022)
Table 43. APAC Liposomal Irinotecan Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Liposomal Irinotecan Revenue Market Share by Region (2017-2022)
Table 45. APAC Liposomal Irinotecan Sales by Type (2017-2022) & (K Units)
Table 46. APAC Liposomal Irinotecan Sales Market Share by Type (2017-2022)
Table 47. APAC Liposomal Irinotecan Sales by Application (2017-2022) & (K Units)
Table 48. APAC Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Table 49. Europe Liposomal Irinotecan Sales by Country (2017-2022) & (K Units)
Table 50. Europe Liposomal Irinotecan Sales Market Share by Country (2017-2022)
Table 51. Europe Liposomal Irinotecan Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Liposomal Irinotecan Revenue Market Share by Country (2017-2022)
Table 53. Europe Liposomal Irinotecan Sales by Type (2017-2022) & (K Units)
Table 54. Europe Liposomal Irinotecan Sales Market Share by Type (2017-2022)
Table 55. Europe Liposomal Irinotecan Sales by Application (2017-2022) & (K Units)
Table 56. Europe Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Liposomal Irinotecan Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Liposomal Irinotecan Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Liposomal Irinotecan Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Liposomal Irinotecan Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Liposomal Irinotecan Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Liposomal Irinotecan Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Liposomal Irinotecan Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Liposomal Irinotecan
Table 66. Key Market Challenges & Risks of Liposomal Irinotecan
Table 67. Key Industry Trends of Liposomal Irinotecan
Table 68. Liposomal Irinotecan Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Liposomal Irinotecan Distributors List
Table 71. Liposomal Irinotecan Customer List
Table 72. Global Liposomal Irinotecan Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Liposomal Irinotecan Sales Market Forecast by Region
Table 74. Global Liposomal Irinotecan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Liposomal Irinotecan Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Liposomal Irinotecan Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Liposomal Irinotecan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Liposomal Irinotecan Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Liposomal Irinotecan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Liposomal Irinotecan Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Liposomal Irinotecan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Liposomal Irinotecan Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Liposomal Irinotecan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Liposomal Irinotecan Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Liposomal Irinotecan Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Liposomal Irinotecan Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Liposomal Irinotecan Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Liposomal Irinotecan Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Liposomal Irinotecan Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Liposomal Irinotecan Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Liposomal Irinotecan Revenue Market Share Forecast by Application (2023-2028)
Table 92. Ipsen Basic Information, Liposomal Irinotecan Manufacturing Base, Sales Area and Its Competitors
Table 93. Ipsen Liposomal Irinotecan Product Offered
Table 94. Ipsen Liposomal Irinotecan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Ipsen Main Business
Table 96. Ipsen Latest Developments
List of Figures
Figure 1. Picture of Liposomal Irinotecan
Figure 2. Liposomal Irinotecan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomal Irinotecan Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Liposomal Irinotecan Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Liposomal Irinotecan Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 43mg
Figure 10. Product Picture of 50mg
Figure 11. Global Liposomal Irinotecan Sales Market Share by Type in 2021
Figure 12. Global Liposomal Irinotecan Revenue Market Share by Type (2017-2022)
Figure 13. Liposomal Irinotecan Consumed in Hospital
Figure 14. Global Liposomal Irinotecan Market: Hospital (2017-2022) & (K Units)
Figure 15. Liposomal Irinotecan Consumed in Drugs Store
Figure 16. Global Liposomal Irinotecan Market: Drugs Store (2017-2022) & (K Units)
Figure 17. Global Liposomal Irinotecan Sales Market Share by Application (2017-2022)
Figure 18. Global Liposomal Irinotecan Revenue Market Share by Application in 2021
Figure 19. Liposomal Irinotecan Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Liposomal Irinotecan Revenue Market Share by Company in 2021
Figure 21. Global Liposomal Irinotecan Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Liposomal Irinotecan Revenue Market Share by Geographic Region in 2021
Figure 23. Global Liposomal Irinotecan Sales Market Share by Region (2017-2022)
Figure 24. Global Liposomal Irinotecan Revenue Market Share by Country/Region in 2021
Figure 25. Americas Liposomal Irinotecan Sales 2017-2022 (K Units)
Figure 26. Americas Liposomal Irinotecan Revenue 2017-2022 ($ Millions)
Figure 27. APAC Liposomal Irinotecan Sales 2017-2022 (K Units)
Figure 28. APAC Liposomal Irinotecan Revenue 2017-2022 ($ Millions)
Figure 29. Europe Liposomal Irinotecan Sales 2017-2022 (K Units)
Figure 30. Europe Liposomal Irinotecan Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Liposomal Irinotecan Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Liposomal Irinotecan Revenue 2017-2022 ($ Millions)
Figure 33. Americas Liposomal Irinotecan Sales Market Share by Country in 2021
Figure 34. Americas Liposomal Irinotecan Revenue Market Share by Country in 2021
Figure 35. United States Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Liposomal Irinotecan Sales Market Share by Region in 2021
Figure 40. APAC Liposomal Irinotecan Revenue Market Share by Regions in 2021
Figure 41. China Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Liposomal Irinotecan Sales Market Share by Country in 2021
Figure 48. Europe Liposomal Irinotecan Revenue Market Share by Country in 2021
Figure 49. Germany Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Liposomal Irinotecan Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Liposomal Irinotecan Revenue Market Share by Country in 2021
Figure 56. Egypt Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Liposomal Irinotecan Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Liposomal Irinotecan in 2021
Figure 62. Manufacturing Process Analysis of Liposomal Irinotecan
Figure 63. Industry Chain Structure of Liposomal Irinotecan
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
